1,507 results on '"Lee, Sunyoung"'
Search Results
52. Characterizing outcomes of ERBB2-amplified biliary tract cancer.
53. A phase 1b/2 study to evaluate the safety and efficacy of TTI-101 as monotherapy and in combination in advanced hepatocellular carcinoma.
54. Characterization of outcomes and genomic alterations (GA) in combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CCA).
55. Serologic, radiographic, and tissue-based markers associated with major pathologic response after treatment with neoadjuvant immunotherapy in patients with resectable hepatocellular carcinoma.
56. Development and evaluation of emulsified reference materials for magnetic resonance imaging
57. Did Recreational Marijuana Legalization Increase Crime in the Long Run?
58. Highly sensitive analytical method for the accurate determination of 5-methyltetrahydrofolic acid monoglutamate in various volumes of human plasma using isotope dilution ultra-high performance liquid chromatography-mass spectrometry
59. Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma Within or Beyond the Milan Criteria: Comparable Long-Term Outcomes
60. PAFAH1B1 haploinsufficiency disrupts GABA neurons and synaptic E/I balance in the dentate gyrus.
61. Prognostic factors of gadoxetic acid–enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma
62. 3% rules the market: herding behavior of a group of investors, asset market volatility, and return to the group in an agent-based model
63. Capital Regulation and Shadow Finance: A Quantitative Analysis.
64. CT and MRI Liver Imaging Reporting and Data System Version 2018 for Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
65. Preoperative CT image-based assessment for estimating risk of ovarian torsion in women with ovarian lesions and pelvic pain
66. Extended application of subtraction arterial phase imaging in LI-RADS version 2018: a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium–enhanced MRI
67. Application of Liver Imaging Reporting and Data System version 2018 ancillary features to upgrade from LR-4 to LR-5 on gadoxetic acid–enhanced MRI
68. Recent progress in development and applications of second near‐infrared (NIR-II) nanoprobes
69. Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapy
70. Escalated‐dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States.
71. Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features.
72. The validation of self-assessment validity in Korean speaking classes using speech-to-text conversation programs
73. Introducing free software for liver volumetry
74. Analytical Methods Based on the Mass Balance Approach for Purity Evaluation of Tetracycline Hydrochloride
75. Capital Regulation and Shadow Finance: A Quantitative Analysis
76. Numerical investigation of wall-pressure fluctuations for Mach 2 turbulent shock-wave boundary layer interactions
77. Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma
78. Differentiation of malignant from benign ampullary strictures: a prediction nomogram based on MR imaging and clinical findings
79. The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
80. Accessory left bile duct draining into the stomach: a case description
81. Evidence to Date: Clinical Utility of Tremelimumab in the Treatment of Unresectable Hepatocellular Carcinoma
82. Application of Unsupervised Learning in Implementation of Joint Power and Index Modulation Access in V2X Systems
83. Diagnostic performance of the LR-M criteria and spectrum of LI-RADS imaging features among primary hepatic carcinomas
84. MMP-2 is a novel histone H3 N-terminal protease necessary for myogenic gene activation
85. Systemic therapy of liver cancer
86. Development of Isotope Dilution-Liquid Chromatography/Mass Spectrometry for the Accurate Determination of Capsaicinoids in Fermented Cabbage Kimchi
87. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline
88. A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma
89. Development of an Isotope Dilution Mass Spectrometry Method for Accurate Determination of Thiamine in Diverse Food Matrices
90. Gadoxetic acid–enhanced MRI as a predictor of recurrence of HCC after liver transplantation
91. Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging
92. Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy
93. 3D printed poly(lactic acid) composites with grafted cellulose nanofibers: Effect of nanofiber and post-fabrication annealing treatment on composite flexural properties
94. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI
95. A kinetic study of ZnO atomic layer deposition: Effects of surface hydroxyl concentration and steric hindrance
96. Homotopy comultiplications on the k-fold wedge of spheres
97. Symmetrically Constrained Compositions
98. A Study on the Direction for the Development of Animation Industry in Developing Countries : Focusing on the Cse of Kenya
99. Segmentation and Rigid Registration of Liver Dynamic Computed Tomography Images for Diagnostic Assessment of Fatty Liver Disease
100. Liver Imaging Reporting and Data System version 2018 category 5 for diagnosing hepatocellular carcinoma: an updated meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.